The FDA said that "serious data gaps" have hindered its ability to craft regulation, including a lack of information on ...
Agency is seeking comment from consumers on products.
The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation ...
The FDA proposes front-of-package "Nutrition Info boxes" to highlight saturated fat, sodium, and added sugars. The initiative aims to combat chronic diseases and promote healthier food choices. Large ...
WASHINGTON — The Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results